Luke Roy Swanson, Chief Technology Officer of Ibotta, Inc. (NASDAQ:IBTA), filed a Form 4 on September 3, 2026, disclosing multiple transactions in Class A Common Stock dated September 1, 2026, including tax-related share withholding and open-market sales executed under a pre-established Rule 10b5-1 trading …
A Form 4 filed with the SEC on September 3, 2026, discloses that Robert A. Bruggeworth, President and CEO of Qorvo, Inc. (NASDAQ:QRVO), sold a combined 28,744 shares of common stock on September 2, 2026, under a pre-established Rule 10b5-1 trading plan.
A Form 4 filed with the SEC on September 3, 2026 discloses that Steven E. Creviston, Senior Vice President of Connectivity and Sensors at Qorvo, Inc. (NASDAQ:QRVO), sold a combined 4,810 shares of common stock on September 2, 2026 under a pre-established Rule 10b5-1 …
Kathleen Patricia Sullivan, Principal Accounting Officer of GCM Grosvenor Inc. (NASDAQ:GCMG), filed a Form 4 on September 3, 2026, reporting the sale of Class A Common Stock on September 2 and September 3, 2026.
Rob Orgel, President and Chief Operating Officer of Flywire Corp, filed a statement of changes in beneficial ownership on September 3, 2026, disclosing a tax-related share withholding event on September 1, 2026.
A Form 4 filed on September 3, 2026 discloses that Paul J. Fego, Senior Vice President of Global Operations at Qorvo, Inc. (NASDAQ:QRVO), sold a combined 2,500 shares of common stock on September 2, 2026 pursuant to a pre-established Rule 10b5-1 trading plan.
David R. King, Chief Product Officer and Co-President of Global Education at Flywire Corp (NASDAQ:FLYW), filed a Form 4 on September 3, 2026, disclosing a share disposition on September 1, 2026, related to the net settlement of restricted stock unit awards.
Jean-Pierre Enguent, Vice President of R&DSS at SEALSQ Corp, filed a Form 4 on September 3, 2026, reporting two transactions in the company's ordinary shares dated September 1 and September 3, 2026.
Director Kevin Bitterman filed a Form 4 with the SEC on September 3, 2026, reporting the sale of common stock of Disc Medicine, Inc. (NASDAQ:IRON) across multiple indirectly held fund accounts on September 1, 2, and 3, 2026, pursuant to a Rule 10b5-1 trading …
Director Mauro Gregorio filed a Form 4 with the SEC on September 3, 2026, disclosing the vesting of 936 restricted stock units and an acquisition of 936 shares of Graham Corporation common stock on September 2, 2026.